Bridgebio Pharma, Inc. · NASDAQ:BBIO

Kumar Neil exercised options for 71,217 Bridgebio Pharma, Inc. shares (Form 4)

Traded Aug 16, 2026 · Filed Aug 18, 2026

On Aug 16, 2026, Kumar Neil (Director, Chief Executive Officer) exercised options for 71,217 Bridgebio Pharma, Inc. shares, leaving 278,307 shares. Filed Aug 18, 2026 (Form 4).

Options exercised
71,217 shares
Holding after
278,307 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 16, 2026Common StockOption exercise33,544276,871Direct
Aug 16, 2026Common StockOption exercise19,599296,470Direct
Aug 16, 2026Common StockOption exercise11,554308,024Direct
Aug 16, 2026Common StockOption exercise6,520314,544Direct
Aug 16, 2026Common StockShares withheld for tax36,237US$79.86278,307Direct

Source

View original at SEC

Related